Check in with UMC’s head of pharmacovigilance science to catch up with her team’s current research priorities.
Research / 09 April 2021
Causality is a tricky business in pharmacovigilance. With limited numbers of adverse event reports, how are we supposed to draw conclusions about causal relationships?
Research / 17 November 2020
Better understanding of genetic variation – between individuals and subpopulations – can inform more refined choices of drugs and doses. A new ISoP group is set to drive progress.
Research / 01 July 2020
Catch up with our research team and find out what's keeping a researcher intrigued right now.
Research / 10 April 2020